Page 1

Interim report January - March 2021 GHP's best quarterly results ■ The results are GHP's best quarterly results so far despite negative effects from the pandemic ■ Great demand for specialty health care means increased focus on organic growth ■ GHP continues to support public sector health care during the pandemic First quarter 2021 ■ Sales revenues increased to SEK 392.9 million ( 383.1 ) ■ Organic growth amounted to 7.1 percent ( 12.3 ) ■ EBITDA increased to SEK 60.9 million ( 54.2 ) ■ EBITDA margin increased to15.5 percent ( 14.2 ) ■ EBIT increased to SEK 34.4 million ( 30.0 ) ■ EBIT margin increased to 8.8 percent ( 7.8 ) " Result after tax increased to SEK 26.1 million ( 23.0 ) ■ Result per share increased to SEK 0.36 ( 0.30 ) Sales revenues , rolling 12 months SEK millions 1 400 1 366 1 347 1 351 1 372 1382 80 1 313 1 276 1 300 1 220 1 172 1 200 60 60 EBIT , rolling 12 months SEK millions 61 59 73 Quality through specialisation 85 80 78 75 72 63 1 100 40 1 000 Q1 Q2 Q3 Q4 2019 2019 2019 2019 Q1 Q2 Q3 Q4 Q1 2020 2020 2020 2020 2021 Q2 Q1 Q3 Q4 Q4 2019 2019 2019 2019 2020 2020 2020 2020 2021 Capital gain of SEK 19.8 million in Q4 2020 is not included in the above graph Q1 02 Q3 Q1 Segment summary Sales revenue Operating result ( EBIT ) Sek millions First quarter First quarter 2021 2020 2021 2020 Nordic region 340.9 324.2 39.9 33.1 International 20.7 29.5 5.9 10.1 Vårdsamverkan 31.3 29.4 0.1 0.1 Other 0.0 0.0 -11.5 -13.3 Total 392.9 383.1 34.4 30.0 Items reported as Other are attributable to Parent Company functions . For more information on the Parent Company's results , please refer to page 17 .